SCHEMBL7149121

SCHEMBL7149121

Cc1ccc(C[C@@H](C)NC[C@H](O)c2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.69
ADRB3 P13945 6/20 0.69
ADRB2 P07550 13/20 0.63
CYP3A4 P08684 3/20 0.57
MAPK1 P28482 3/20 0.57
NPSR1 Q6W5P4 2/20 0.57
CYP2D6 P10635 1/20 0.57
TSHR P16473 1/20 0.57
HIF1A Q16665 1/20 0.57
HSD17B10 Q99714 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
PTGS1 P23219 1/20 0.57
SLC6A2 P23975 1/20 0.57
HTR2A P28223 1/20 0.57
SLC6A4 P31645 1/20 0.57
MC4R P32245 1/20 0.57
ADRA1A P35348 1/20 0.57
OPRM1 P35372 1/20 0.57
MC3R P41968 1/20 0.57
SLC6A3 Q01959 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149120 1.00 ADRB1 (0.69) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL10892816 1.00 ADRB1 (0.69) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL10890456 1.00 ADRB1 (0.69) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7144066 0.94 ADRB2 (0.68) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7144068 0.94 ADRB2 (0.68) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7937104 0.91 ADRB2 (0.75) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7149115 0.91 ADRB2 (0.75) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7149113 0.91 ADRB2 (0.75) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL9468422 0.89 ADRB1 (0.80) ADRB1ADRB3ADRB2CYP3A4MAPK1
SCHEMBL7151262 0.89 ADRB1 (0.80) ADRB1ADRB3ADRB2CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0085514-A2 Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals BEECHAM GROUP PLC (GB) 1983-08-10 EP claimed
US-20030143701-A1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEMICAL INDUSTRIES, LTD. 2003-07-31 US disclosed
EP-0924194-B1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEM (JP) 2003-05-14 EP disclosed
US-6528686-B1 Reacting primary amine and ketone functionalized derivatives; catalytically reducing DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-03-04 US disclosed
EP-0924193-B1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEM (JP) 2003-02-19 EP disclosed
EP-0939134-B1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEM (JP) 2002-09-11 EP disclosed
US-6114582-A DECYCLIZATION TO FORM A CHEMICAL INTERMEDIATE FOR PRODUCING AN ANTI-OBESITY AGENT AND ANTIDIABETIC AGENT DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-09-05 US disclosed
EP-0654534-B1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEM (JP) 2000-03-01 EP disclosed
EP-0939134-A1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-09-01 EP disclosed
EP-0924193-A1 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-06-23 EP disclosed
EP-0924194-A2 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-06-23 EP disclosed
US-5629200-A MICROORGANISM DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1997-05-13 US disclosed
EP-0654534-A2 Processes for producing optically active 2-amino-1-phenylethanol derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1995-05-24 EP disclosed
US-4588749-A ANTIOBESITY AND HYPOGLYCEMIC AGENTS BEECHAM GROUP P.L.C. (GB) 1986-05-13 US disclosed
EP-0040000-B1 ARYLETHANOLAMINE DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP PLC (GB) 1983-10-12 EP disclosed
EP-0040000-A1 Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-11-18 EP disclosed